11. August 2017

Production of a document on good in vitro practices in collaboration with the European Commission and the OECD.
The document went into the second public consultation round:

http://www.oecd.org/env/ehs/testing/OECD%20Draft%20GIVIMP_v05%20-%20clean.pdf

http://www.oecd.org/env/ehs/testing/draft-guidance-review-documents-monographs.htm

Background information: There is a scientific policy and regulatory desire for validated and internationally accepted in vitro methods (e.g. OECD test guidelines or ISO standards). To accommodate the needs of regulatory authorities, a number of in vitro methods, often based on the use of human cells and tissues, have been submitted to international validation bodies during the last two decennia. However, the experience gained during these validations revealed that many in vitro methods need significant improvements in design, robustness and reliability before they can be successfully implemented in a routine laboratory environment to generate data sets, which can be used to support regulatory decisions. GIVIMP specifies these improvements.

15. May 2017

Workshop on ‘developmental and reproductive toxicity (DART) test methods’

The workshop was held in collaboration with BASF and CAAT-Europe in the historical concilium building. International experts worked on a roadmap for improved DART testing to support development of new compounds, reduce the use of animals, and increase safety of the population

5. May 2017

Publication of our first screening paper to identify unknown toxicants together with the National Toxicology Program, USA (NTP) and the Computational Toxicology unit at University of Pompeu Fabra (Barcelona). We define strategies for ‘hit’ (= positive screen result) confirmation and hit follow-up in the field of toxicology.

(http://link.springer.com/article/10.1007/s00204-017-1977-y)

https://www.ncbi.nlm.nih.gov/pubmed/28477266

Nyffeler J, Dolde X, Krebs A, Pinto-Gil K, Pastor M, Behl M, Waldmann T, Leist M. (2017) Combination of multiple neural crest migration assay to identify environmental toxicants from a proof-of-concept chemical library. Arch Toxicol, 10.1007/s00204-017-1977-y

29. April 2017

Publication of a large systems toxicology-oriented review on the MPTP Parkinson’s disease model, together with leading experts involved in the initial discovery of the underlying toxicant (D. DiMonte, DZNE, Bonn), and  in contemporary landmark discoveries concerning new mechanisms (K. Tieu, Miami).

 (http://www.sciencedirect.com/science/article/pii/S0165614717300780)

 Schildknecht S, Di Monte DA, Pape R, Tieu K, Leist M (2017) Tipping points and endogenous determinants of nigrostriatal degeneration by MPTP. Trends Pharmacol Sci, in press doi: 10.1016/j.tips.2017.03.010

27. April 2017

Workshop on ‘Data management and data processing in large European projects’ with 28 international participants in the Concilium location in Konstanz. Co-Organised by CAAT-Europe (M. Daneshian), Douglas Connect (Basel) and the European Bioinfomatics Institute (EBI, Cambridge)

5. April 2017

Our new paper on interferon developmental hazard is out 

 https://www.ncbi.nlm.nih.gov/pubmed/28365849

Pallocca G, Nyffeler J, Dolde X, Grinberg M, Gstraunthaler G, Waldmann T, Rahnenführer J, Sachinidis A, Leist M. Impairment of human neural crest cell migration by prolonged exposure to interferon-beta. Arch Toxicol. 2017

16. March 2017

 The EFSA opinion ‘A new path to toxicity assessment’ is officially published

 http://www.efsa.europa.eu/en/press/news/170316

We worked hard on this, and on the embedded adverse outcome pathway (AOP) examining a relevant link of pesticides and Parkinson’s disease (link)

 https://aopwiki.org/aops/3

7.March 2017

M. Leist receives the ‘GT-toxicology award’ at the German Toxicology Summit in Heidelberg for excellent publications in the previous year